These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2394612)

  • 1. Tumor and normal tissue tolerance for fractionated low-dose-rate radiotherapy.
    Moulder JE; Fish BL; Wilson JF
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):341-8. PubMed ID: 2394612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S; Trisler K; Wessels BW; Knox SJ
    Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equivalence of hyperfractionated and continuous brachytherapy in a rat tumor model and remarkable effectiveness when preceded by external irradiation.
    Veninga T; Visser AG; van den Berg AP; van Hooije CM; van Geel CA; Levendag PC
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1351-60. PubMed ID: 11286843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined fractionated external beam radiotherapy and low-dose-rate iodine-125 seeds in an experimental tumor system.
    Würschmidt F; Fassbender T; Beck-Bornholdt HP
    Strahlenther Onkol; 2000 Nov; 176(11):524-7. PubMed ID: 11143527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
    King CR
    Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments.
    Visser AG; van den Aardweg GJ; Levendag PC
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):497-505. PubMed ID: 8567354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
    Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IUdR polymers for combined continuous low-dose rate and high-dose rate sensitization of experimental human malignant gliomas.
    Yuan X; Dillehay LE; Williams JR; Shastri VR; Williams JA
    Int J Cancer; 2001 Apr; 96(2):118-25. PubMed ID: 11291095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of breast cancer irradiation treatment with low-dose-rate external irradiation.
    Pierquin B; Tubiana M; Pan C; Lagrange JL; Calitchi E; Otmezguine Y
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):117-21. PubMed ID: 17189067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
    Sminia P; Schneider CJ; Fowler JF
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
    Pop LA; Millar WT; Visser AG; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures.
    Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
    Int J Radiat Biol; 2005 Sep; 81(9):689-99. PubMed ID: 16368647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer.
    Zaider M; Zelefsky MJ; Cohen GN; Chui CS; Yorke ED; Ben-Porat L; Happersett L
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):702-13. PubMed ID: 15708248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-effect relation of interstitial low-dose-rate radiation (Ir192) in an animal tumor model.
    Ruifrok AC; Levendag PC; Lakeman RF; Deurloo IK; Visser AG
    Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):31-6. PubMed ID: 2298632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between fractionated high dose rate irradiation and continuous low dose rate irradiation in spheroids.
    Omura M; Torigoe S; Kurihara H; Matsubara S; Kubota N
    Acta Oncol; 1998; 37(7-8):681-6. PubMed ID: 10050987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG; Sarkaria JN; Potter DM; Schink JC
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiobiological aspects of continuous low dose-rate irradiation and fractionated high dose-rate irradiation.
    Turesson I
    Radiother Oncol; 1990 Sep; 19(1):1-15. PubMed ID: 2236638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of the antitumor effect of radiolabeled monoclonal antibodies.
    Knox SJ; Levy R; Miller RA; Uhland W; Schiele J; Ruehl W; Finston R; Day-Lollini P; Goris ML
    Cancer Res; 1990 Aug; 50(16):4935-40. PubMed ID: 2379158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.